| 1 | 551-11-1 | 地诺前列素 | dinoprost | C20H34O5
| 合成;引产药;中间体;前列素类;科研试剂;科研原料;生化试剂;前列腺素类;医药原料药 | |
| 2 | 180469-63-0 | 5-iPF2α-VI | 5-iPF2α-VI | C20H34O5
| | |
| 3 | 23518-25-4 | 人前列腺素F2(PGF2)ELISA试剂盒 | (+-)-PGF2-alpha | C20H34O5
| 试剂盒-Elisa试剂盒 | |
| 4 | 745-65-3 | 前列腺素E1 | Prostaglandin E1 | C20H34O5
| 药物;脂类;中间体;原料药;抑制剂;前列素;前列腺素;医药原料;前列素类;精细化工 | 成品药 |
| 5 | | PGF2ALPHA [1-14C] | PGF2ALPHA [1-14C] | C20H34O5
| | |
| 6 | 1445349-99-4 | 8,12-iso-iPF2α-VI | 8,12-iso-iPF2α-VI | C20H34O5
| | |
| 7 | 38360-96-2 | (+)-Prostaglandin E1 | (+)-Prostaglandin E1 | C20H34O5
| | |
| 8 | 20348-58-7 | (+-)-Prostaglandin E1 | (+-)-Prostaglandin E1 | C20H34O5
| | |
| 9 | 20897-91-0 | 15(R)-PROSTAGLANDIN E1 | 15(R)-PROSTAGLANDIN E1 | C20H34O5
| | |
| 10 | 24570-01-2 | 11-Β-前列腺素 E1 | 11BETA-PROSTAGLANDIN E1 | C20H34O5
| | |
| 11 | 38776-77-1 | 10-Deoxygrayanotoxin III | 10-Deoxygrayanotoxin III | C20H34O5
| | |
| 12 | 177020-26-7 | 8-ISO PROSTAGLANDIN F2BETA | 8-ISO PROSTAGLANDIN F2BETA | C20H34O5
| | |
| 13 | 37658-84-7 | 15(R)-PROSTAGLANDIN F2ALPHA | 15(R)-PROSTAGLANDIN F2ALPHA | C20H34O5
| 化学物质-生化物质 | 化学物质-生化物质 |
| 14 | 159812-83-6 | ent-8-iso Prostaglandin F2α | ent-8-iso Prostaglandin F2α | C20H34O5
| | |
| 15 | 21562-58-3 | 15-KETO PROSTAGLANDIN F1ALPHA | 15-KETO PROSTAGLANDIN F1ALPHA | C20H34O5
| | |
| 16 | 38432-87-0 | 11BETA-PROSTAGL AND IN F2ALPHA | 11BETA-PROSTAGL AND IN F2ALPHA | C20H34O5
| | |
| 17 | 4510-16-1 | 同分异构体(物),同质异能素 | 9BETA, 11ALPHA-PROSTAGLANDIN F2 | C20H34O5
| | |
| 18 | 214748-65-9 | 8-ISO-15(R)-PROSTAGLANDIN F2ALPHA | 8-ISO-15(R)-PROSTAGLANDIN F2ALPHA | C20H34O5
| | |
| 19 | 214748-66-0 | ent-8-iso-15(S)-Prostaglandin F2α | ent-8-iso-15(S)-Prostaglandin F2α | C20H34O5
| | |
| 20 | 5094-14-4 | 13,14-二氢-15-酮-前列腺素E1 | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1 | C20H34O5
| 小分子 | |
| 21 | 95560-45-5 | 4,5-环氧六氢化-1,2-苯二甲酸二己酯 | Dihexyl-4,5-epoxyhexahydro-1,2-phthalate | C20H34O5
| | |
| 22 | 27376-76-7 | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA | C20H34O5
| 生化试剂 | |
| 23 | 102910-23-6 | 5,12,20-trihydroxy-6,8,14-eicosatrienoic acid | 5,12,20-trihydroxy-6,8,14-eicosatrienoic acid | C20H34O5
| | |
| 24 | 102910-24-7 | 5,12,20-trihydroxy-8,10,14-eicosatrienoic acid | 5,12,20-trihydroxy-8,10,14-eicosatrienoic acid | C20H34O5
| | |
| 25 | | 8-ISO-13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA | 8-ISO-13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA | C20H34O5
| | |
| 26 | 17968-82-0 | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID | C20H34O5
| | |
| 27 | 96790-36-2 | (5E,9E,14E)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | (5E,9E,14E)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | C20H34O5
| | |
| 28 | | (5Z,8Z,12E)-11,14,15-trihydroxyicosa-5,8,12-trienoic acid | (5Z,8Z,12E)-11,14,15-trihydroxyicosa-5,8,12-trienoic acid | C20H34O5
| | |
| 29 | 67008-19-9 | (13E,15S)-6,9α-Epoxy-11α,15-dihydroxyprost-13-en-1-oic acid | (13E,15S)-6,9α-Epoxy-11α,15-dihydroxyprost-13-en-1-oic acid | C20H34O5
| | |
| 30 | | 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid dihexyl ester | 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid dihexyl ester | C20H34O5
| | |
| 31 | 68860-46-8 | (5Z,9E,11R,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | (5Z,9E,11R,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | C20H34O5
| | |
| 32 | | (5Z,8Z,11S,12R,14Z)-10,11,12-trihydroxyicosa-5,8,14-trienoic acid | (5Z,8Z,11S,12R,14Z)-10,11,12-trihydroxyicosa-5,8,14-trienoic acid | C20H34O5
| | |
| 33 | 152561-64-3 | (+)-1-Decarboxy-1-methyl-20-nor-19-carboxyprostaglandin F(sub 2-alpha) | (+)-1-Decarboxy-1-methyl-20-nor-19-carboxyprostaglandin F(sub 2-alpha) | C20H34O5
| | |
| 34 | 191919-02-5 | (Z)-7-((1S,2R,3R,5S)-3,5-二羟基-2-(3-氧代辛基)环戊基)庚-5-烯酸 | (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | C20H34O5
| | |
| 35 | | (4Z,9E)-6,8-Dihydroxy-4,8-dimethyl-11-(1-methylethyl)-14-oxopentadeca-4,9-dienoic acid | (4Z,9E)-6,8-Dihydroxy-4,8-dimethyl-11-(1-methylethyl)-14-oxopentadeca-4,9-dienoic acid | C20H34O5
| | |
| 36 | 119314-69-1 | 7-[(1R,2S,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent yl]heptanoic acid | 7-[(1R,2S,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent yl]heptanoic acid | C20H34O5
| | |
| 37 | 67441-54-7 | 4-(5-Hydroxy-4,8-dimethyl-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid | 4-(5-Hydroxy-4,8-dimethyl-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid | C20H34O5
| | |
| 38 | 99877-56-2 | 2-Hydroxy-9-[3-(5-hydroxy-3-hydroxymethyl-3-pentenyl)-2-methyloxiranyl]-2,6-dimethyl-3-nonen-5-one | 2-Hydroxy-9-[3-(5-hydroxy-3-hydroxymethyl-3-pentenyl)-2-methyloxiranyl]-2,6-dimethyl-3-nonen-5-one | C20H34O5
| | |
| 39 | 90639-07-9 | (2S,αS,α'R)-α-(Hydroxymethyl)-α'-[[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-(hydroxymethyl)-1,2α,4aβ-trimethylnaphthalen-1α-yl]methyl]-2,2-oxiranedimethanol | (2S,αS,α'R)-α-(Hydroxymethyl)-α'-[[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-(hydroxymethyl)-1,2α,4aβ-trimethylnaphthalen-1α-yl]methyl]-2,2-oxiranedimethanol | C20H34O5
| | |
| 40 | 53823-01-1 | (5'R,3S,2R,4''aR)-4,5,3',4',3'',4'',4a'',5'',6'',7'',8'',8a''-Dodecahydro-5''α-(hydroxymethyl)-2''α,5'',8''aβ-trimethyldispiro[furan-3(2H),2'(5'H)-furan-5',1''(2''H)-naphthalene]-2,6''β-diol | (5'R,3S,2R,4''aR)-4,5,3',4',3'',4'',4a'',5'',6'',7'',8'',8a''-Dodecahydro-5''α-(hydroxymethyl)-2''α,5'',8''aβ-trimethyldispiro[furan-3(2H),2'(5'H)-furan-5',1''(2''H)-naphthalene]-2,6''β-diol | C20H34O5
| | |